ArticleBasic and clinical andrology2026
Association of sperm DNA fragmentation index with semen quality and ART outcomes: real-world evidence from a retrospective cohort.
Article in Basic and clinical andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Elevated sperm DNA fragmentation is associated with embryonic developmental attrition after fertilization in conventional IVF cycles.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSperm DNA fragmentation index (DFI) has emerged as a potential marker of male fertility, but its clinical value in assisted reproductive technology (ART) remains debated. This study aimed to investigate the association between sperm DFI and conventional semen parameters, embryological outcomes, and pregnancy outcomes in ART, using a large real-world dataset.
resultsA total of 1,784 ART cycles performed at a single center between January 2020 and January 2022 were analyzed. Patients were categorized into normal (< 30%) and high (≥ 30%) DFI groups. Compared with the normal DFI group, men with high DFI had significantly lower sperm concentration (B = − 31.15, 95% CI: − 44.75 to − 17.55), progressive motility (B = − 12.21, 95% CI: − 14.87 to − 9.56), and total motility (B = − 18.00, 95% CI: − 21.38 to − 14.62; all P < 0.001). After adjusting for female and male factors, high DFI was associated with a significantly lower 2PN fertilization rate (β = − 0.257, 95% CI: − 0.491 to − 0.024, P = 0.031), while no significant differences were observed in top-quality embryo rate, transferable embryo rate, or pregnancy outcomes. Sensitivity analyses using alternative statistical methods (ZOIB and PSM) and varying DFI thresholds (25% and 35%) yielded results completely consistent with the main analyses.
conclusionsHigh sperm DFI is independently associated with poorer semen quality and a reduced 2PN fertilization rate but was not significantly associated with embryo quality or pregnancy outcomes in this study. These findings support the clinical relevance of DFI in evaluating male fertility potential while suggesting its limited predictive value for ART success when female and cycle-related factors are considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.